CD44s antibody | knockout validation | R&D systems BBA10

This is a knockout-validated antibody summary, based on the publication "Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

CD44s antibody | knockout validation | R&D systems BBA10 figure 1
Figure 1. Western blot analysis of CD44 in virally infected control (Ctrl), CD44-knocked out (K.O.), and CD44-reconstituted HeLa cells. From [1].
Antibody information

Mouse monoclonal IgG2A

Company: R&D systems

Antibody: CD44s

Catalog number: BBA10

Summary: Mouse monoclonal IgG2A against a recombinant human CD44v3-10 (includes the invariant N-terminal exons and CD44v3-10 exons). Reacts with human by western blot, immunohistochemistry, immunoprecipitation and flow cytometry. This antibody recognizes an epitope in the invariant N-terminal region of all CD44 protein isoforms.

Validation Method

Western blot

Sample

Control, CD44-knocked out (K.O.), and CD44-reconstituted HeLa cells.

Primary incubation

1:500 dilution.

Secondary incubation

Horseradish peroxidase conjugated secondary (1:10,000; Santa Cruz Biotechnology, Cat# sc-2005 or 1:100,000; EMD Millipore, Cat# AP130P).

Detection

SuperSignal West Pico chemiluminescent substrate (Pierce) or SuperSignal West Femto chemiluminescent substrate (Pierce).

References
  1. Murakami T, Kim J, Li Y, Green G, Shikanov A, Ono A. Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions. Nat Commun. 2018;9:2436 pubmed publisher